-+ 0.00%
-+ 0.00%
-+ 0.00%

Definium Therapeutics grants 88,900 inducement stock options to new hires

PUBT·08/31/2026 20:01:36
Listen to the news
Definium Therapeutics grants 88,900 inducement stock options to new hires
  • Definium Therapeutics issued inducement stock options for 88,900 common shares to three newly hired non-executive employees.
  • Grants carry an effective date of Aug. 31, 2026, with an exercise price set at the stock’s closing price that day.
  • Vesting schedule spans four years: 25% after one year, remaining 75% in substantially equal monthly installments over the next three years.
  • Awards were issued under the company’s 2026 Inducement Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260831011570) on August 31, 2026, and is solely responsible for the information contained therein.